@parkerwalther.bsky.social
Reposted
We’re excited to highlight a new offering from Greenstone: chamber-specific 3D cardiac organoids.
Each cryopreserved vial contains approximately 300 organoids, with more than 85% resuming spontaneous contractions after being thawed.
Learn more here: www.linkedin.com/feed/update/...
Each cryopreserved vial contains approximately 300 organoids, with more than 85% resuming spontaneous contractions after being thawed.
Learn more here: www.linkedin.com/feed/update/...
September 11, 2025 at 6:07 PM
We’re excited to highlight a new offering from Greenstone: chamber-specific 3D cardiac organoids.
Each cryopreserved vial contains approximately 300 organoids, with more than 85% resuming spontaneous contractions after being thawed.
Learn more here: www.linkedin.com/feed/update/...
Each cryopreserved vial contains approximately 300 organoids, with more than 85% resuming spontaneous contractions after being thawed.
Learn more here: www.linkedin.com/feed/update/...
Reposted
We’re excited to discuss a new tool in our platform Greenstone: hiPSC-derived intestinal organoids.
Greenstone has successfully reprogrammed iPSCs into intestinal organoids through two intermediate stages: endoderm and midgut.
Learn more here: www.linkedin.com/feed/update/...
Greenstone has successfully reprogrammed iPSCs into intestinal organoids through two intermediate stages: endoderm and midgut.
Learn more here: www.linkedin.com/feed/update/...
#greenstonebiosciences #nams #newapproachmethodologies #ipsc | Greenstone Biosciences
Continuing our spotlight on New Approach Methodologies (NAMs), we’re excited to highlight another powerful tool in our platform: hiPSC-derived intestinal organoids.
The Greenstone Biosciences team ha...
www.linkedin.com
September 18, 2025 at 6:06 PM
We’re excited to discuss a new tool in our platform Greenstone: hiPSC-derived intestinal organoids.
Greenstone has successfully reprogrammed iPSCs into intestinal organoids through two intermediate stages: endoderm and midgut.
Learn more here: www.linkedin.com/feed/update/...
Greenstone has successfully reprogrammed iPSCs into intestinal organoids through two intermediate stages: endoderm and midgut.
Learn more here: www.linkedin.com/feed/update/...